Kohorn E I
Yale Trophoblast Center, Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut 06520-8063, USA.
J Reprod Med. 1998 Jan;43(1):33-6.
The present situation of staging gestational trophoblastic tumors by the system of the International Federation of Obstetrics and Gynecology (FIGO) and of scoring systems of risk factors in such tumors is examined critically. A solution for resolving staging and scoring difficulties is offered by combining the present FIGO staging with the accepted standardized World Health Organization system.
对国际妇产科联合会(FIGO)系统对妊娠滋养细胞肿瘤进行分期的现状以及此类肿瘤危险因素评分系统的现状进行了批判性审视。通过将现行的FIGO分期与公认的标准化世界卫生组织系统相结合,为解决分期和评分难题提供了一种解决方案。